Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - NET INCOME
Net Income NVO - Novo Nordisk A/S
83.7 B
LAST VALUE
32.37%
2 YEAR CAGR
16.72%
5 YEAR CAGR
12.76%
10 YEAR CAGR